{"entity":{"type":"insider","cik":"0001502917","url":"/insider/0001502917","json_url":"/insider/0001502917.json","name":"Stamoulis Christiana","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":10,"first":"2013-05-01","last":"2025-10-22","span_basis":"filed_date"},"name_variants":[{"name":"Stamoulis Christiana","source":"filing","n_filings":10,"first_seen":"2013-05-01","last_seen":"2025-10-22"}],"transactions":[{"id":4903309,"accession":"0000859737-25-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000859737-25-000030","line_url":"/filing/0000859737-25-000030#line-2","is_derivative":false,"issuer_cik":"0000859737","issuer_name":"HOLOGIC INC","issuer_ticker":"HOLX","issuer_name_source":null,"issuer_url":"/issuer/0000859737","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7402.0,"shares_display":"7,402","price_per_share":73.07,"price_display":"73.07","price_state":"stated","total_value":540864.14,"total_display":"540,864.14","total_whole":"540,864","shares_owned_after":47336.0,"shares_owned_after_display":"47,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-20","filed_date":"2025-10-22","scope":"insider"},{"id":2308870,"accession":"0001127602-24-020732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-020732","line_url":"/filing/0001127602-24-020732#line-2","is_derivative":false,"issuer_cik":"0000859737","issuer_name":"HOLOGIC INC","issuer_ticker":"HOLX","issuer_name_source":null,"issuer_url":"/issuer/0000859737","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9039.0,"shares_display":"9,039","price_per_share":79.5,"price_display":"79.50","price_state":"stated","total_value":718600.5,"total_display":"718,600.50","total_whole":"718,601","shares_owned_after":45472.0,"shares_owned_after_display":"45,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider"},{"id":3290966,"accession":"0001127602-20-028361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-028361","line_url":"/filing/0001127602-20-028361#line-2","is_derivative":false,"issuer_cik":"0000859737","issuer_name":"HOLOGIC INC","issuer_ticker":"HOLX","issuer_name_source":null,"issuer_url":"/issuer/0000859737","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11146.0,"shares_display":"11,146","price_per_share":74.0,"price_display":"74.00","price_state":"stated","total_value":824804.0,"total_display":"824,804.00","total_whole":"824,804","shares_owned_after":39392.0,"shares_owned_after_display":"39,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider"},{"id":8708798,"accession":"0001127602-19-033757","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-19-033757","line_url":"/filing/0001127602-19-033757#line-2","is_derivative":false,"issuer_cik":"0000859737","issuer_name":"HOLOGIC INC","issuer_ticker":"HOLX","issuer_name_source":null,"issuer_url":"/issuer/0000859737","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12306.0,"shares_display":"12,306","price_per_share":49.75,"price_display":"49.75","price_state":"stated","total_value":612223.5,"total_display":"612,223.50","total_whole":"612,224","shares_owned_after":37175.0,"shares_owned_after_display":"37,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-26","scope":"insider"},{"id":6154542,"accession":"0001127602-18-034840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-034840","line_url":"/filing/0001127602-18-034840#line-2","is_derivative":false,"issuer_cik":"0000859737","issuer_name":"HOLOGIC INC","issuer_ticker":"HOLX","issuer_name_source":null,"issuer_url":"/issuer/0000859737","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13257.0,"shares_display":"13,257","price_per_share":44.501,"price_display":"44.50","price_state":"stated","total_value":589949.757,"total_display":"589,949.76","total_whole":"589,950","shares_owned_after":35039.0,"shares_owned_after_display":"35,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-28","filed_date":"2018-11-30","scope":"insider"},{"id":6295648,"accession":"0001127602-18-029589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-029589","line_url":"/filing/0001127602-18-029589#line-2","is_derivative":false,"issuer_cik":"0000859737","issuer_name":"HOLOGIC INC","issuer_ticker":"HOLX","issuer_name_source":null,"issuer_url":"/issuer/0000859737","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30967.0,"shares_display":"30,967","price_per_share":40.704,"price_display":"40.70","price_state":"stated","total_value":1260480.768,"total_display":"1,260,480.77","total_whole":"1,260,481","shares_owned_after":35039.0,"shares_owned_after_display":"35,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-02","filed_date":"2018-10-04","scope":"insider"},{"id":5132816,"accession":"0001209191-13-037018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-037018","line_url":"/filing/0001209191-13-037018","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark":"O","role_mark_label":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp Strategy & Bus Devlp","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":86.346,"price_display":"86.35","price_state":"stated","total_value":97139.25,"total_display":"97,139.25","total_whole":"97,139","shares_owned_after":40812.0,"shares_owned_after_display":"40,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-15","filed_date":"2013-07-17","scope":"insider","n_lines":2},{"id":4425090,"accession":"0001209191-13-035979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-035979","line_url":"/filing/0001209191-13-035979","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark":"O","role_mark_label":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp Strategy & Bus Devlp","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4687.0,"shares_display":"4,687","price_per_share":81.20643055259228,"price_display":"81.21","price_state":"stated","total_value":380614.54,"total_display":"380,614.54","total_whole":"380,615","shares_owned_after":40712.0,"shares_owned_after_display":"40,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-05","filed_date":"2013-07-09","scope":"insider","n_lines":2},{"id":5478681,"accession":"0001209191-13-027215","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-027215","line_url":"/filing/0001209191-13-027215","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark":"O","role_mark_label":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp Strategy & Bus Devlp","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":602.0,"shares_display":"602","price_per_share":79.64943521594684,"price_display":"79.65","price_state":"stated","total_value":47948.96,"total_display":"47,948.96","total_whole":"47,949","shares_owned_after":40812.0,"shares_owned_after_display":"40,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-17","scope":"insider","n_lines":2},{"id":5335828,"accession":"0001209191-13-023348","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-13-023348","line_url":"/filing/0001209191-13-023348#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark":"O","role_mark_label":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp Strategy & Bus Devlp","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":77.88,"price_display":"77.88","price_state":"stated","total_value":77.88,"total_display":"77.88","total_whole":"78","shares_owned_after":40712.0,"shares_owned_after_display":"40,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-01","scope":"insider"},{"id":5335822,"accession":"0001209191-13-023348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-023348","line_url":"/filing/0001209191-13-023348","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001502917","owner_name":"Stamoulis Christiana","owner_display_name":"Stamoulis Christiana","owner_url":"/insider/0001502917","role":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark":"O","role_mark_label":"Officer (SVP, Corp Strategy & Bus Devlp)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp Strategy & Bus Devlp","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82999.0,"shares_display":"82,999","price_per_share":79.50404330172653,"price_display":"79.50","price_state":"stated","total_value":6598756.09,"total_display":"6,598,756.09","total_whole":"6,598,756","shares_owned_after":40712.0,"shares_owned_after_display":"40,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-29","filed_date":"2013-05-01","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000859737","name":"HOLOGIC INC","url":"/issuer/0000859737","role":"Director","n_filings":6,"first_seen":"2018-10-04","last_seen":"2025-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (SVP, Corp Strategy & Bus Devlp)","n_filings":4,"first_seen":"2013-05-01","last_seen":"2013-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001502917","retrieved_at":"2026-08-27T10:59:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}